Redeye states that both sales and profitability were lower than estimated.
Redeye comments on AVTECH's key figures, which showed strong and profitable growth, with revenue up ...
Q2 report due on 22 July We move sales slightly further into the future Our positive LT perspective ...
Redeye comments on Beijer Group's Q2 2022, which showed all-time highs in order intake, sales, and E...
Redeye maintains its valuation and positive view of Orexo after the Q2 report.
Stark resultatutveckling i Q2'22 BE Group levererade ett underliggande rörelseresultat på 291 mkr i ...
Verkkokauppa.com’s Q2 EBIT fell short of our expectations.
Redeye comments on the news that Careium’s CEO Carl-Johan Zetterberg Boudrie is set to leave his pos...
Utmanande omvärldsfaktorer Q2'22 ITAB rapporterade en EBIT på 55 mkr (38), 79 mkr (81) exklusive jäm...
Negativ organisk tillväxt då bolaget ökar fokus på vinsten.
In Q2, the first ASTar remains in the stage of expanding the lead prospect pipeline.
Q2 report due Tuesday, 23 August We expect 167% adj.
Best net leasing in company history (since 2020) Net operating income (-1%) hurt by energy costs 2.
Q2: 4% sales beat due to 8% better device sales Likely core markets that are performing well New mar...
Redeye endorses that ChloraSolv now is available in the UK through NHS Supply Chain.
The Thoracic recovery continues, and the organic growth in constant currencies is a robust 24% compa...
Fuud announced today a SEK 23m convertible loan from Formue Nord Fokus A/S.
Strong margin trend continued in Q2 We increase ’22e-’24e adj.
We expect a solid Q2 for Inission, albeit still hampered by headwinds related to costs and supply.
Elanders presented a strong Q2 report, with 11% organic growth for Supply Chain Solutions, driven by...
